Guardant Health Inc. (5GH)
XDUS
150.68
+8.08 (+5.67%)
Closed
Oct 21, 2026
Day's Range
143.86150.68
52 wk Range
57.54167.12
Financial Statements - 5GH - Guardant Health Inc.
Revenue
982.02M▲ 57.0%
Net Income
-416.27M▼ 12.7%Net Margin -42.4%
EBITDA
-373.90M▼ 13.2%
Free Cash Flow
-233.06M▼ 0.1%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 982.02M | 625.65M | 563.94M | 449.53M | 373.65M | 286.73M |
| Cost of Goods | 349M | 245.34M | 227.05M | 156.32M | 122.91M | 92.53M |
| Gross Profit | 633.01M | 380.30M | 336.89M | 293.21M | 250.74M | 194.19M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -437.24M | -375.54M | -564.72M | -544.37M | -411M | -254.95M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -10.49M | -36.06M | 53.17M | -112.56M | 25.17M | 3.64M |
| Pre Tax Income | -417.54M | -368.34M | -478.76M | -653.44M | -384.47M | -245.90M |
| Income Tax | -1.26M | 1.08M | 685K | 1.13M | 300K | 379K |
| Net Income | -416.27M | -369.43M | -479.44M | -654.58M | -384.77M | -246.28M |
| EPS Basic | -3.32 | -3.56 | -4.28 | -6.41 | -4 | -2.6 |
| EPS Diluted | -3.32 | -3.56 | -4.28 | -6.41 | -4 | -2.6 |
| Basic Shares Outstanding | 125.37M | 103.91M | 116.54M | 106.33M | 105.43M | 101.47M |
| Diluted Shares Outstanding | 125.37M | 103.91M | 116.54M | 106.33M | 105.43M | 101.47M |
| Ebit | -413.64M | -366.16M | -476.18M | -650.87M | -381.89M | -241.13M |
| Ebitda | -373.90M | -330.27M | -433.30M | -614.91M | -359.62M | -225.07M |
| Net Income Continuous Operations | -416.27M | -369.43M | -479.44M | -654.58M | -384.77M | -246.28M |
| Minority Interests | - | - | 0 | 0 | -20.90M | -7.50M |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
